Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence
AbstractBackground. Skull base meningiomas are considered to be difficult for surgical treatment. We wondered whether genetic alterations recently identified
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2017
|
| In: |
Neuro-Oncology
Year: 2017, Jahrgang: 19, Heft: 8, Pages: 1088-1096 |
| ISSN: | 1523-5866 |
| DOI: | 10.1093/neuonc/nox018 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1093/neuonc/nox018 Verlag, Volltext: https://academic.oup.com/neuro-oncology/article/19/8/1088/3800501 
|
| Verfasserangaben: | Ümmügülsüm Yesilöz, Elmar Kirches, Christian Hartmann, Johannes Scholz, Siegfried Kropf, Felix Sahm, Makoto Nakamura, and Christian Mawrin |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1576923770 | ||
| 003 | DE-627 | ||
| 005 | 20220816085436.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180627s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/neuonc/nox018 |2 doi | |
| 035 | |a (DE-627)1576923770 | ||
| 035 | |a (DE-576)506923770 | ||
| 035 | |a (DE-599)BSZ506923770 | ||
| 035 | |a (OCoLC)1341013048 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Yesilöz, Ümmügülsüm |d 1993- |e VerfasserIn |0 (DE-588)1161835881 |0 (DE-627)1025294920 |0 (DE-576)506923568 |4 aut | |
| 245 | 1 | 0 | |a Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence |c Ümmügülsüm Yesilöz, Elmar Kirches, Christian Hartmann, Johannes Scholz, Siegfried Kropf, Felix Sahm, Makoto Nakamura, and Christian Mawrin |
| 246 | 3 | 3 | |a Frequent AKT1 E 17 K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence |
| 264 | 1 | |c 2017 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published: 06 May 2017 | ||
| 500 | |a Gesehen am 27.06.2018 | ||
| 500 | |a Im Titel ist "E17K" hochgestellt | ||
| 520 | |a AbstractBackground. Skull base meningiomas are considered to be difficult for surgical treatment. We wondered whether genetic alterations recently identified | ||
| 700 | 1 | |a Kirches, Elmar |e VerfasserIn |0 (DE-588)120574844X |0 (DE-627)1691384194 |4 aut | |
| 700 | 1 | |a Hartmann, Christian |e VerfasserIn |0 (DE-588)1030180539 |0 (DE-627)734895240 |0 (DE-576)377991465 |4 aut | |
| 700 | 1 | |a Scholz, Johannes |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kropf, Siegfried |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sahm, Felix |d 1984- |e VerfasserIn |0 (DE-588)1022852132 |0 (DE-627)717318478 |0 (DE-576)366075020 |4 aut | |
| 700 | 1 | |a Nakamura, Makoto |d 1972- |e VerfasserIn |0 (DE-588)121733904 |0 (DE-627)081499736 |0 (DE-576)292856865 |4 aut | |
| 700 | 1 | |a Mawrin, Christian |d 1972- |e VerfasserIn |0 (DE-588)122598504 |0 (DE-627)082040826 |0 (DE-576)293342687 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neuro-Oncology |d Oxford : Oxford Univ. Press, 1999 |g 19(2017), 8, Seite 1088-1096 |h Online-Ressource |w (DE-627)357167341 |w (DE-600)2094060-9 |w (DE-576)318041839 |x 1523-5866 |7 nnas |a Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence |
| 773 | 1 | 8 | |g volume:19 |g year:2017 |g number:8 |g pages:1088-1096 |g extent:9 |a Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/neuonc/nox018 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://academic.oup.com/neuro-oncology/article/19/8/1088/3800501 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180627 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 1022852132 |a Sahm, Felix |m 1022852132:Sahm, Felix |d 910000 |d 912000 |e 910000PS1022852132 |e 912000PS1022852132 |k 0/910000/ |k 1/910000/912000/ |p 6 | ||
| 998 | |g 1030180539 |a Hartmann, Christian |m 1030180539:Hartmann, Christian |d 50000 |e 50000PH1030180539 |k 0/50000/ |p 3 | ||
| 999 | |a KXP-PPN1576923770 |e 3014057827 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"titleAlt":[{"title":"Frequent AKT1 E 17 K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence"}],"note":["Published: 06 May 2017","Gesehen am 27.06.2018","Im Titel ist \"E17K\" hochgestellt"],"relHost":[{"pubHistory":["1.1999 -"],"language":["eng"],"origin":[{"publisher":"Oxford Univ. Press ; Duke University Medical Center","publisherPlace":"Oxford ; Durham, NC","dateIssuedKey":"1999","dateIssuedDisp":"1999-"}],"id":{"issn":["1523-5866"],"eki":["357167341"],"zdb":["2094060-9"]},"part":{"volume":"19","extent":"9","issue":"8","pages":"1088-1096","text":"19(2017), 8, Seite 1088-1096","year":"2017"},"disp":"Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrenceNeuro-Oncology","title":[{"title":"Neuro-Oncology","title_sort":"Neuro-Oncology","subtitle":"official journal of the World Federation of Neuro-Oncology"}],"physDesc":[{"extent":"Online-Ressource"}],"recId":"357167341","note":["Gesehen am 21.07.23"],"type":{"bibl":"periodical","media":"Online-Ressource"}}],"recId":"1576923770","physDesc":[{"extent":"9 S."}],"name":{"displayForm":["Ümmügülsüm Yesilöz, Elmar Kirches, Christian Hartmann, Johannes Scholz, Siegfried Kropf, Felix Sahm, Makoto Nakamura, and Christian Mawrin"]},"title":[{"title":"Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence","title_sort":"Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence"}],"person":[{"role":"aut","display":"Yesilöz, Ümmügülsüm","family":"Yesilöz","given":"Ümmügülsüm"},{"given":"Elmar","display":"Kirches, Elmar","role":"aut","family":"Kirches"},{"given":"Christian","role":"aut","display":"Hartmann, Christian","family":"Hartmann"},{"role":"aut","display":"Scholz, Johannes","family":"Scholz","given":"Johannes"},{"family":"Kropf","role":"aut","display":"Kropf, Siegfried","given":"Siegfried"},{"given":"Felix","role":"aut","display":"Sahm, Felix","family":"Sahm"},{"given":"Makoto","family":"Nakamura","display":"Nakamura, Makoto","role":"aut"},{"role":"aut","display":"Mawrin, Christian","family":"Mawrin","given":"Christian"}],"id":{"doi":["10.1093/neuonc/nox018"],"eki":["1576923770"]},"origin":[{"dateIssuedDisp":"2017","dateIssuedKey":"2017"}],"language":["eng"]} | ||
| SRT | |a YESILOEZUEFREQUENTAK2017 | ||